Literature DB >> 22477500

Should symptomatic, isolated distal deep vein thrombosis be treated with anticoagulation?

Ashish Anil Sule1, Tay Jam Chin, Pankaj Handa, Arul Earnest.   

Abstract

BACKGROUND: During the past two decades, the diagnosis of deep venous thrombosis (DVT) has made considerable progress. The term distal or calf vein thrombosis includes thrombosis in infrapopliteal veins, including the posterior tibial, peroneal, anterior tibial and muscular calf veins. The necessity of treating of distal DVT is debatable.
OBJECTIVE: To determine whether treatment of isolated, distal DVT with anticoagulation versus no treatment affects patient outcome.
METHODS: All patients discharged with a diagnosis of distal DVT from Tan Tock Seng Hospital, Singapore, between January 1, 2006, and December 31, 2007, were identified by the medical records office of the hospital. Compression of the intraluminal thrombus by duplex scan was used to diagnose distal DVT. Excluded were patients who either had both distal and proximal DVT, or had distal DVT along with pulmonary embolism (PE) at presentation. Complete resolution of distal DVT on repeat duplex scan was used to measure the primary outcome. Repeat follow-up scans were performed at two weeks, one month, three months and six months, or on subsequent follow-up until the distal DVT had resolved completely. Secondary outcome measures were complete improvement of symptoms, progression of thrombosis, or PE or death during the follow-up period. The study included 68 patients with distal DVT; however, 17 patients with PE, two of whom had proximal DVT (in the iliac and common femoral veins) at the first presentation along with distal DVT, were excluded from the study. In total, 51 patients were included for analysis. The follow-up scan was available in 35 patients; therefore, the primary analysis was performed in 35 patients (47 incidences of distal DVT). However, the secondary analysis was available in all 51 patients. Of the 35 patients available for follow-up scans, 17 patients (25 incidences of distal DVT) received anticoagulation and 18 patients (22 incidences of distal DVT) received no anticoagulation. Of the 17 patients who were treated with anticoagulation, nine patients (13 incidences of distal DVT) received enoxaparin at a dose of 1 mg/kg twice a day for two weeks and eight patients (12 incidences of distal DVT) received warfarin for a period of three months with initial overlap of enoxaparin 1 mg/kg twice a day for three to five days. Once the prothrombin time international normalized ratio of a patient on warfarin was between 2 and 3, enoxaparin was discontinued. The 18 patients who did not receive anticoagulation received follow-up with regular duplex scan.
RESULTS: There were no statistically significant differences among the groups in the resolution of distal DVT or symptom improvement with or without treatment. In the group that received no treatment, one death occurred. Proximal extension and PE were not recorded in any of the patients.
CONCLUSION: Distal DVT may not require treatment with anticoagulation. If leg symptoms worsen, or if there is an extension of distal DVT on the follow-up scan, treatment with anticoagulation is recommended.

Entities:  

Year:  2009        PMID: 22477500      PMCID: PMC2780853          DOI: 10.1055/s-0031-1278332

Source DB:  PubMed          Journal:  Int J Angiol        ISSN: 1061-1711


  18 in total

1.  Early outcome after isolated calf vein thrombosis.

Authors:  M H Meissner; M T Caps; R O Bergelin; R A Manzo; D E Strandness
Journal:  J Vasc Surg       Date:  1997-11       Impact factor: 4.268

2.  Does this patient have deep vein thrombosis?

Authors:  S S Anand; P S Wells; D Hunt; P Brill-Edwards; D Cook; J S Ginsberg
Journal:  JAMA       Date:  1998-04-08       Impact factor: 56.272

3.  Major bleeding during anticoagulation after cerebral ischemia: patterns and risk factors. Stroke Prevention In Reversible Ischemia Trial (SPIRIT). European Atrial Fibrillation Trial (EAFT) study groups.

Authors:  J W Gorter
Journal:  Neurology       Date:  1999-10-12       Impact factor: 9.910

4.  Prediction of the risk of bleeding during anticoagulant treatment for venous thromboembolism.

Authors:  P M Kuijer; B A Hutten; M H Prins; H R Büller
Journal:  Arch Intern Med       Date:  1999-03-08

5.  Prospective evaluation of an index for predicting the risk of major bleeding in outpatients treated with warfarin.

Authors:  R J Beyth; L M Quinn; C S Landefeld
Journal:  Am J Med       Date:  1998-08       Impact factor: 4.965

6.  Clinical relevance of distal deep vein thrombosis. Review of literature data.

Authors:  Marc Righini; Samuel Paris; Grégoire Le Gal; Jean-Pierre Laroche; Arnaud Perrier; Henri Bounameaux
Journal:  Thromb Haemost       Date:  2006-01       Impact factor: 5.249

7.  Lower extremity calf thrombosis: to treat or not to treat?

Authors:  J M Lohr; T M Kerr; K S Lutter; R D Cranley; K Spirtoff; J J Cranley
Journal:  J Vasc Surg       Date:  1991-11       Impact factor: 4.268

8.  Color-flow duplex scanning for the surveillance and diagnosis of acute deep venous thrombosis.

Authors:  M A Mattos; G L Londrey; D W Leutz; K J Hodgson; D E Ramsey; L D Barkmeier; E S Stauffer; D P Spadone; D S Sumner
Journal:  J Vasc Surg       Date:  1992-02       Impact factor: 4.268

9.  Deep venous thrombosis and the risk of pulmonary embolism. A systematic study.

Authors:  M Monreal; J Ruíz; A Olazabal; A Arias; J Roca
Journal:  Chest       Date:  1992-09       Impact factor: 9.410

10.  Pulmonary embolism in patients with isolated soleal vein thrombosis.

Authors:  S Ohgi; M Tachibana; M Ikebuchi; Y Kanaoka; T Maeda; T Mori
Journal:  Angiology       Date:  1998-09       Impact factor: 3.619

View more
  3 in total

1.  Management of complications after rotator cuff surgery.

Authors:  Stephen A Parada; Matthew F Dilisio; Colin D Kennedy
Journal:  Curr Rev Musculoskelet Med       Date:  2015-03

2.  Cost-Effectiveness of Alternative Anticoagulation Strategies for Postoperative Management of Total Knee Arthroplasty Patients.

Authors:  Savannah R Smith; Jeffrey N Katz; Elena Losina
Journal:  Arthritis Care Res (Hoboken)       Date:  2019-11-05       Impact factor: 4.794

Review 3.  Transient portal vein thrombosis in liver cirrhosis.

Authors:  Xingshun Qi; Xiaozhong Guo; Eric M Yoshida; Nahum Méndez-Sánchez; Valerio De Stefano; Frank Tacke; Andrea Mancuso; Yasuhiko Sugawara; Sien-Sing Yang; Rolf Teschke; Ankur Arora; Dominique-Charles Valla
Journal:  BMC Med       Date:  2018-06-05       Impact factor: 8.775

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.